Answers are grounded in this paper and cite their sources.
(See the Major Article by Grant et al on pages e2117–23.) Transgender populations experience disproportionately high rates of new human immunodeficiency virus (HIV) infections. In the United States, an estimated 2% of transgender men and 19% of transgender women are living with HIV, including 44% of Black or African American transgender women and 26% of Latinx transgender women [1]. Many transgender individuals experience stigma, socioeconomic disadvantages, and psychological distress that can increase vulnerability to HIV infection while also impeding access to HIV preventive services [2]. An effective and equitable response to the HIV epidemic must prioritize prevention strategies that are tailored to meet the needs of transgender people. Antiretroviral preexposure prophylaxis (PrEP) is highly effective at decreasing HIV transmission and could be a potent tool to address HIV-related inequities for transgender populations. However, few transgender individuals have used PrEP. Barriers have included limited awareness of PrEP,...
No takes yet. Share an insight, caveat, or question.
Douglas Krakower (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: